Oruka Therapeutics (ORKA) Live Share Price, Invest From India

Oruka Therapeutics Stock Performance

as on September 15, 2026 at 6:13 am IST

Day's Low
Day's High
$92.55
Day's Price Range
$96.23
$96.11
3.70%
Downside
0.12%
Upside
52 Week's Low
52 Week's High
$14.67
52-Week Price Range
$115.52
$96.11
84.74%
Downside
20.19%
Upside

Oruka Therapeutics share price movements today

Previous Close: $92.38
Open: $92.55
Volume: 476.2K
Market Cap: $6.1B
Day's Low - High: $92.55 - $96.23
52 Week Low - High: $14.67 - $115.52

Oruka Therapeutics Historical Returns

1 Month Return: -16.8 %
3 Month Return: + 32.18 %
1 Year Return: + 499.87 %
3 Year Return: 0 %
5 Year Return: 0 %

Oruka Therapeutics Stock Fundamentals & Key Indicators

Check Oruka Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.1B

EPS (TTM)

-2.47

Dividend Yield

0.00%

PE Ratio (TTM)

-37.4

Industry PE ratio

-15.40

PEG Ratio

-0.6898642491389816

Return On Equity TTM

-20.76%

Oruka Therapeutics Stock Valuation

Track how Oruka Therapeutics P/E has moved over time to understand its valuation trends.

Oruka Therapeutics in the last 5 years

Overview
Trends

Lowest (-41.29x)

December 31, 2022

Industry (-15.40x)

December 31, 2025

Today (-13.12x)

December 31, 2025

Highest (-3.89x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -13.12x

Oruka Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oruka Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Oruka Therapeutics	StrongBuy	$6.1B	NA	-37.4	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$130.6B	173.57%	29.76	86.04%	NA
Moderna	BUY	$57.5B	-66.34%	-18.04	-12.57%	NA
Regeneron	BUY	$80.5B	21.13%	18.66	84.86%	47.339999999999996%

Stock Returns calculator for Oruka Therapeutics Stock including INR - Dollar returns

The Oruka Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Oruka Therapeutics investment value today

Current value as on today

₹6,76,626

Returns

₹5,76,626

(+576.63%)

Returns from Oruka Therapeutics Stock

₹5,24,091 (+524.09%)

Dollar Impact

₹52,535 (+52.54%)

Analyst Recommendation on Oruka Therapeutics Stock

Based on 11 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 11 analysts, 100% of analysts recommend a 'BUY' rating for Oruka Therapeutics. Average target price of $156.4

Indian Investors' Interest in Oruka Therapeutics Stock

Search interest for Oruka Therapeutics Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2026 to September 15, 2026

Change:-22% versus previous 30 day period

Oruka Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	-	-	-	-	-	0	0	0
Operating Income	-2	-21	-29	-38	-25	-28	-34	-34	-36	-50
EBITDA	-1	-22	-28	-37	-20	-24	-30	-29	-31	-50
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	0	0	-	0	0	0	0	0	0	0
Income Before Tax	-2	-22	-28	-33	-20	-24	-30	-29	-31	-41
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-2	-22	-28	-33	-20	-24	-30	-29	-31	-41
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Oruka Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0
Operating Income	-18	-8	-5	-9	-19	-9	-88	-122
EBITDA	-18	-7	-5	-9	-19	-9	-82	-105
Interest Expense	-	-	0	0	-	-	1	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-18	-7	-5	-9	-19	-9	-83	-105
Income Tax Expense	0	0	0	0	-	-	-	-
Net Income	-18	-7	-5	-9	-19	-9	-83	-105
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Oruka Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-2	-28	-25	-20	-24	-30	-29	-31	-41
Operating Cash Flow	0	-2	-34	-18	-20	-23	-21	-22	-23	-33
Investing Cash Flow	-	-	0	-329	42	4	-122	-22	-14	-410
Financing Cash Flow	27	0	450	0	-	0	169	0	40	663
Change in Cash	27	-2	377	-349	21	-18	25	-44	2	218

Oruka Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024	Dec 2025
Net Income	-18	-7	-5	-9	-19	-9	-83	-105
Operating Cash Flow	-17	-8	-4	-7	-18	-10	-57	-88
Investing Cash Flow	12	3	0	0	0	0	-330	-96
Financing Cash Flow	5	3	6	48	23	-	449	170
Change in Cash	1	-2	1	40	4	-10	24	-14

Mutual Funds that own Oruka Therapeutics Stock

Check out the Mutual Funds with significant holdings in Oruka Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	2.736763%	1812003
Fidelity Select Portfolios	2.238785%	1482293
Fidelity Securities Fund	2.20941%	1462844
Fidelity Advisor Series VII	1.754102%	1161386
Fidelity Mt. Vernon Street Trust	0.960587%	636002

See all

Global Institutional Holdings in Oruka Therapeutics

Funds	Holdings
Peter Harwin	5.6%
Vanguard	4.22%
iShares	3.64%
SPDR	2.71%
Peter Kolchinsky	2.35%

See all

Oruka Therapeutics News & Key Events

Insights on Oruka Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ORKA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 year, ORKA stock has moved up by 499.9%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 12.5%

About Oruka Therapeutics

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Organisation	Oruka Therapeutics
Headquarters	855 Oak Grove Avenue, Menlo Park, CA, United States, 94025
Industry	Biotechnology
CEO	Dr. Lawrence Otto Klein Ph.D.
E-voting on shares	Click here to vote

Key Management of Oruka Therapeutics

Name	Title
Mr. Paul T. Quinlan	General Counsel & Secretary
Dr. Joana Goncalves M.D.	Chief Medical Officer
Mr. Alan Lada	VP of IR & Capital Markets
Mr. Christopher Finch	Senior VP and Head of Business Development & Strategy
Dr. Rajiv Panwar	Senior VP and Head of Chemistry, Manufacturing & Controls
Dr. Lawrence Otto Klein Ph.D.	President, CEO & Director
Mr. Arjun Agarwal CPA	Senior VP of Finance & Treasurer
Ms. Laura Sandler	Chief Operating Officer
Mr. Larry Todd Edwards	Chief Commercial Officer

FAQs

What is Oruka Therapeutics share price today?

Oruka Therapeutics share price today is $96.11 as on September 15, 2026 at 12:43 am IST. Oruka Therapeutics share today touched a day high of $96.23 and a low of $92.55.

What is the 52 week high and 52 week low for Oruka Therapeutics share?

Oruka Therapeutics share touched a 52 week high of $115.52 on August 19, 2026 and a 52 week low of $14.67 on September 16, 2025. Oruka Therapeutics stock price today i.e. September 15, 2026 at 12:43 am IST is trending at $96.11,which is 16.80% down from its 52 week high and 555.37% up from its 52 week low.

What is Oruka Therapeutics's market capitalisation today?

Oruka Therapeutics market capitalisation is $0.01T as on September 15, 2026 at 12:43 am IST.

How to invest in Oruka Therapeutics Stock (ORKA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oruka Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oruka Therapeutics Shares that will get you 0.0156 shares as per Oruka Therapeutics share price of $96.11 per share as on September 15, 2026 at 12:43 am IST.

What is the minimum amount required to buy Oruka Therapeutics Stock (ORKA) from India?

Indian investors can start investing in Oruka Therapeutics (ORKA) shares with as little as ₹95.54 or $1 (as of September 15, 2026 at 12:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Oruka Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 15, 2026 at 12:43 am IST). Based on Oruka Therapeutics share’s latest price of $96.11 as on September 15, 2026 at 12:43 am IST, you will get 0.1040 shares of Oruka Therapeutics. Learn more about fractional shares .